Grant: DRA : Canada Graduate Research Scholarship - Doctoral Program (CGRS D)
University of Ottawa
$120,000.00
Enhancing Neural Regeneration After Spinal Cord Injury through NSPC Stimulation and iPSC-Derived Therapies
FY 2025-26
Summary
Spinal cord injuries affect thousands of Canadians each year and often lead to lifelong paralysis or loss of independence. Today's treatments can limit further damage but they cannot rebuild the injured spinal cord. My research aims to change that by improving stem cell-based therapies. I will study two types of cells that can become new spinal cord cells: (1) natural neural stem cells from donated human tissue, and (2) cells made from a patient's own skin that are reprogrammed into "induced pluripotent stem cells" (iPSCs) and then guided to become neural stem cells.
First, I will learn how human neural stem cells respond to inflammation and other signals after injury, and compare those responses to cells from commonly used animal models. This will reveal where animal data does-and does not-match human biology.
Second, I will use what we learn from authentic human cells to improve iPSC-derived cells. By adjusting growth conditions and activating key molecular pathways, the goal is to make patient-matched cells safer, more resilient, and better at replacing damaged tissue.
Finally, I will test the most promising approaches in advanced lab models that mimic the injured spinal cord to see if the cells survive, connect with existing circuits, and restore function.
This project directly addresses a major barrier in the field: therapies that work in animals often fail in people. By grounding the work in human biology and tailoring iPSC-based treatments to patients, the results could accelerate clinical trials and deliver more effective, personalized options for people living with spinal cord injury. As a neurosurgery resident and PhD trainee working with leading Canadian teams, I will translate these findings toward therapies that improve independence and quality of life.
Department
Program
DRA : Canada Graduate Research Scholarship - Doctoral Program (CGRS D)
Recipient
Location
Ontario, Canada
Recipient Type
Academia
Type
Grant
Source
CIHR Funding Decisions Database
As published
Id
559038
Name
Sandarage Ryan V
Region
Ontario
Country
Canada
Orgtype
Institution Paid; Research Institution
Instname2
Neurosciences, Mental Health and Addiction
Theme2
Biomedical
Prcname2
DT1 (Biomedical and/or Clinical Research) CGRS Doctoral
Projecttitle
Enhancing Neural Regeneration After Spinal Cord Injury through NSPC Stimulation and iPSC-Derived Therapies
Programtype2
Studentship Programs
Orgnameinp2
University of Ottawa
Cihramount2
$120,000
Cihrequipment2
$0
Programname2
DRA : Canada Graduate Research Scholarship - Doctoral Program (CGRS D)
Keyworddelim
Axonal Regeneration & Remyelination; Cell Therapy / Cell Replacement; Human Vs Animal Model Comparison; Induced Pluripotent Stem Cells (Ipscs); Neural Stem/Progenitor Cells (Nspcs); Neuroinflammation; Regenerative Medicine; Single-Cell Rna-Seq (Scrna-Seq); Spinal Cord Injury (Sci); Translational Neuroscience
Abstract
Spinal cord injuries affect thousands of Canadians each year and often lead to lifelong paralysis or loss of independence. Today's treatments can limit further damage but they cannot rebuild the injured spinal cord. My research aims to change that by improving stem cell-based therapies. I will study two types of cells that can become new spinal cord cells: (1) natural neural stem cells from donated human tissue, and (2) cells made from a patient's own skin that are reprogrammed into "induced pluripotent stem cells" (iPSCs) and then guided to become neural stem cells.
First, I will learn how human neural stem cells respond to inflammation and other signals after injury, and compare those responses to cells from commonly used animal models. This will reveal where animal data does-and does not-match human biology.
Second, I will use what we learn from authentic human cells to improve iPSC-derived cells. By adjusting growth conditions and activating key molecular pathways, the goal is to make patient-matched cells safer, more resilient, and better at replacing damaged tissue.
Finally, I will test the most promising approaches in advanced lab models that mimic the injured spinal cord to see if the cells survive, connect with existing circuits, and restore function.
This project directly addresses a major barrier in the field: therapies that work in animals often fail in people. By grounding the work in human biology and tailoring iPSC-based treatments to patients, the results could accelerate clinical trials and deliver more effective, personalized options for people living with spinal cord injury. As a neurosurgery resident and PhD trainee working with leading Canadian teams, I will translate these findings toward therapies that improve independence and quality of life.
Competitiondate
202511
Approvedterm2
3 yrs 0 mth
Pinamesdelim
Sandarage, Ryan V
Approvedterm
3 ans 0 mois
Cihrcontribution2
~ $120,000~ $0~